{"id":53511,"date":"2023-02-01T13:02:18","date_gmt":"2023-02-01T12:02:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/"},"modified":"2023-02-01T13:02:18","modified_gmt":"2023-02-01T12:02:18","slug":"beigene-to-present-at-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/","title":{"rendered":"BeiGene to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p>CAMBRIDGE, Mass. &amp; BASEL, Switzerland &amp; BEIJING&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24BGNE&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$BGNE<\/a> <a href=\"https:\/\/twitter.com\/hashtag\/BeiGene?src=hash\" target=\"_blank\" rel=\"noopener\">#BeiGene<\/a>&#8211;BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company,<b> <\/b>today announced that the Company will participate in two upcoming investor conferences:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230201005204\/en\/1612468\/5\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230201005204\/en\/1612468\/21\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nThe Guggenheim Oncology Conference 2023 on Wednesday, February 8, 2023 at 9:35 a.m. ET; and\n<\/li>\n<li>\nThe SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 1:40 p.m. ET.\n<\/li>\n<\/ul>\n<p>\nLive webcasts of these events can be accessed from the investors section of BeiGene\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fir.beigene.com&amp;esheet=53295938&amp;newsitemid=20230201005204&amp;lan=en-US&amp;anchor=http%3A%2F%2Fir.beigene.com&amp;index=1&amp;md5=24fc0684667a0afc536de16d8c2f7262\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/ir.beigene.com<\/a> and archived replays will be available for 90 days following the events.\n<\/p>\n<p>\n<b>About BeiGene<\/b>\n<\/p>\n<p>\nBeiGene is a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and access for far more patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 9,000 colleagues spans five continents, with administrative offices in Cambridge, U.S., &amp; Basel, Switzerland &amp; Beijing, China. To learn more about BeiGene, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.beigene.com&amp;esheet=53295938&amp;newsitemid=20230201005204&amp;lan=en-US&amp;anchor=www.beigene.com&amp;index=2&amp;md5=e658e1d51510d034ca644837a527c1f1\" rel=\"nofollow noopener\" shape=\"rect\">www.beigene.com<\/a> and follow us on Twitter at @BeiGeneGlobal.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor:<\/b><br \/>Kevin Mannix<br \/>\n<br \/>+1 240-410-0129<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x69;&#114;&#x40;&#98;&#x65;&#105;&#x67;&#101;&#x6e;&#101;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#105;&#x72;&#64;&#98;&#x65;i&#103;&#x65;n&#x65;&#x2e;&#99;&#x6f;m<\/a><\/p>\n<p><b>Media:<\/b><br \/>Kyle Blankenship<br \/>\n<br \/>+1 667- 351-5176<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;:me&#x64;&#x69;&#x61;&#x40;&#98;&#101;ige&#x6e;&#x65;&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#x65;&#x64;&#105;&#97;&#64;b&#x65;&#x69;&#x67;&#x65;&#110;&#101;&#46;c&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass. &amp; BASEL, Switzerland &amp; BEIJING&#8211;(BUSINESS WIRE)&#8211;$BGNE #BeiGene&#8211;BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in two upcoming investor conferences: The Guggenheim Oncology Conference 2023 on Wednesday, February 8, 2023 at 9:35 a.m. ET; and The SVB Securities Global Biopharma Conference on Wednesday, February &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53511","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BeiGene to Present at Upcoming Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BeiGene to Present at Upcoming Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass. &amp; BASEL, Switzerland &amp; BEIJING&#8211;(BUSINESS WIRE)&#8211;$BGNE #BeiGene&#8211;BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in two upcoming investor conferences: The Guggenheim Oncology Conference 2023 on Wednesday, February 8, 2023 at 9:35 a.m. ET; and The SVB Securities Global Biopharma Conference on Wednesday, February ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-01T12:02:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230201005204\/en\/1612468\/21\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"BeiGene to Present at Upcoming Investor Conferences\",\"datePublished\":\"2023-02-01T12:02:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/\"},\"wordCount\":220,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201005204\\\/en\\\/1612468\\\/21\\\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/\",\"name\":\"BeiGene to Present at Upcoming Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201005204\\\/en\\\/1612468\\\/21\\\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg\",\"datePublished\":\"2023-02-01T12:02:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201005204\\\/en\\\/1612468\\\/21\\\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230201005204\\\/en\\\/1612468\\\/21\\\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/beigene-to-present-at-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BeiGene to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BeiGene to Present at Upcoming Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"BeiGene to Present at Upcoming Investor Conferences - Pharma Trend","og_description":"CAMBRIDGE, Mass. &amp; BASEL, Switzerland &amp; BEIJING&#8211;(BUSINESS WIRE)&#8211;$BGNE #BeiGene&#8211;BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in two upcoming investor conferences: The Guggenheim Oncology Conference 2023 on Wednesday, February 8, 2023 at 9:35 a.m. ET; and The SVB Securities Global Biopharma Conference on Wednesday, February ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-01T12:02:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230201005204\/en\/1612468\/21\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"BeiGene to Present at Upcoming Investor Conferences","datePublished":"2023-02-01T12:02:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/"},"wordCount":220,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230201005204\/en\/1612468\/21\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/","name":"BeiGene to Present at Upcoming Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230201005204\/en\/1612468\/21\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg","datePublished":"2023-02-01T12:02:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230201005204\/en\/1612468\/21\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230201005204\/en\/1612468\/21\/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/beigene-to-present-at-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"BeiGene to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53511"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53511\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}